“…15 Since Berners-Price reported the anticancer properties of Au(I)-NHC complexes in 2004, 16 considerable efforts have been dedicated to the investigation of metal NHC complexes, such as Au, Ag, Pd, Pt, Cu, Ru, and Ir, as antineoplastic agents. [17][18][19][20][21][22] In combination of our interest in the development of novel NHCs ligands [23][24][25][26][27][28] and our experience with benzimidazole carbenes, [29][30][31] we herein report a new route for the synthesis NHC-Rh complexes with benzimidazole backbone using simple 1,2-dibromobenzene as starting material. Considering the promising potential of rhodium complexes as therapeutic molecules, [32][33][34][35][36][37][38][39] these new complexes were evaluated for cytotoxicity against MCF-7 human breast cancer cells and most of the synthesized complexes showed excellent activities.…”